Skip to content

Outside Dhaka delivery charge 130/- advance payable · Cash on delivery all over Bangladesh

Ehavene
Orili 200mg Tablet
Orili 200mg Tablet
Square Pharmaceuticals PLC

Orili 200mg Tablet

Be the first to review SKU: OT200MG
৳2,820

Orili is indicated for the management of moderate to severe pain associated with endometriosis.

Delivery

Inside Dhaka: 1–2 days · Outside Dhaka: 2–4 days

Cash on Delivery

Pay when you receive your order.

Returns

Easy 7-day return & exchange

Category
Tablet & Capsules
Brand
Square Pharmaceuticals PLC

Product details

Orili 200mg Tablet

Elagolix is a GnRH receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland. Administration of Elagolix results in dose-dependent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased blood concentrations of the ovarian sex hormones, estradiol and progesterone.

Interaction

With medicine: May potentiate P-gp substrates (e.g. digoxin), CYP2C19 substrates (e.g. omeprazole; limit doses to <40 mg daily). May antagonize CYP3A substrates. Antagonizes oral midazolam, rosuvastatin; consider increasing their doses. May be antagonized by CYP3A inducers. Reduced efficacy with estrogen-containing contraceptives.

With food and others: No known food interaction.

Contraindications

It is contraindicated in pregnant women because exposure to Elagolix early in pregnancy may increase the risk of early pregnancy loss. With known osteoporosis, it can increase the risk of further bone loss. It is also contraindicated for severe hepatic impairment and also with concomitant use of strong organic anion transporting polypeptide OATP1B1 inhibitors (e.g. cyclosporine and gemfibrozil).

Side Effects

Common: The most common side effects include hot flushes, night sweats, headache, nausea, amenorrhea, , arthralgia, mood changes & bone loss. Rare: Insomnia, anxiety & elevated hepatic transaminase.

Pregnancy & Lactation

The limited human data with the use of Elagolix in pregnant women are insufficient to determine whether there is a risk for major birth defects or miscarriage. Exposure to Elagolix early in pregnancy may increase the risk of early pregnancy loss. Use of it is contraindicated in pregnant women. Elagolix has to be discontinued if pregnancy occurs during treatment. There is no information on the presence of elagolix or its metabolites in human milk, the effects on the breastfed child or the effects on milk production.

Use in Special Populations

No dose adjustment of Orili is required in women with any degree of renal impairment or end-stage renal disease (including women on dialysis)No dosage adjustment of Orili is required in women with mild hepatic impairment.Safety and effectiveness of Orili in patients less than 18 years of age have not been established.

Overdose Effects

In case of overdose, patients should be monitored for any signs or symptoms of adverse reactions and initiate appropriate symptomatic treatment, as needed.

Therapeutic Class

Gonadotropin-releasing hormone (GnRH) antagonist

Storage Conditions

Store in a cool & dry place, protect from light & moisture. Keep all medicines out of reach of children.

0.0
★★★★★★★★★★

0 reviews

5★ 0
4★ 0
3★ 0
2★ 0
1★ 0

Write a review

⭐

No reviews yet

Bought this product? Share your experience to help others.

You may also like

Recently viewed

Orili 200mg Tablet

৳2,820

Cash on Delivery
07 Days Return
100% Authentic
Support 24/7